Muzastotug is under clinical development by Adagene Suzhou and currently in Phase II for Hepatocellular Carcinoma.

North Carolina construction worker Derek Barnett, 55, lost more than 70 pounds on a unique nutrition and fitness journey after being diagnosed with liver cancer.

乙型肝炎病毒（Hepatitis B virus,HBV）感染是重要的公共卫生问题，估计全球流行率为3.8%，影响全球约2.96亿人。慢性乙型肝炎（chronic hepatitis ...

Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, ...

本文综合自：Whole grain and dietary fiber intake and risk of colorectal cancer in the NIH-AARP Diet and Health Study cohort ...

Tevimbra is under clinical development by BeiGene and currently in Phase III for Hepatocellular Carcinoma. According to GlobalData, Phase III drugs for Hepatocellular Carcinoma have a 47% phase ...

Advances in therapy are improving outcomes for patients, but the incidence and mortality rates for hepatocellular carcinoma ...

Announcing a new publication for Acta Materia Medica journal. Fatty acid (FA) reprogramming has a significant role in liver cancer. However, the contribution of FA metabolism reprogramming to the ...